...
首页> 外文期刊>Molecules >Design, Synthesis, Binding and Docking-Based 3D-QSAR Studies of 2-Pyridylbenzimidazoles-A New Family of High Affinity CB1 Cannabinoid Ligands
【24h】

Design, Synthesis, Binding and Docking-Based 3D-QSAR Studies of 2-Pyridylbenzimidazoles-A New Family of High Affinity CB1 Cannabinoid Ligands

机译:设计,合成,结合和基于对接的3D-QSAR研究2-吡啶基苯并咪唑-一种新的高亲和力CB1大麻素配体家族。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of novel 2-pyridylbenzimidazole derivatives was rationally designed and synthesized based on our previous studies on benzimidazole 14, a CB1 agonist used as a template for optimization. In the present series, 21 compounds displayed high affinities with Ki values in the nanomolar range. JM-39 (compound 39) was the most active of the series (KiCB1 = 0.53 nM), while compounds 31 and 44 exhibited similar affinities to WIN 55212-2. CoMFA analysis was performed based on the biological data obtained and resulted in a statistically significant CoMFA model with high predictive value (q~2 = 0.710, r~2 = 0.998, r_(pred)~2 = 0.823).
机译:根据我们以前对苯并咪唑14的研究,合理设计和合成了一系列新颖的2-吡啶基苯并咪唑衍生物,CB1激动剂用作优化模板。在本系列中,有21种化合物显示出高亲和力,Ki值在纳摩尔范围内。 JM-39(化合物39)是该系列中活性最高的化合物(KiCB1 = 0.53 nM),而化合物31和44表现出与WIN 55212-2相似的亲和力。根据获得的生物学数据进行CoMFA分析,得出具有统计学意义的CoMFA模型,具有较高的预测值(q〜2 = 0.710,r〜2 = 0.998,r_(pred)〜2 = 0.823)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号